Dr. Jonathan James Corbett , MD
Urology • Worthington, OH
350 W Wilson Bridge Rd Ste 100
Worthington, OH 430852590
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 8, 2015; this date does not establish years in practice.
-
Published CMS data list 10,800 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J9030 — Bcg live intravesical instillation, 1 mg: 3,650 service units.
- J0897 — Injection, denosumab, 1 mg: 3,060 service units.
- Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml: 1,100 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 37 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,056 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 452 prescription fills, including refills.
- Oxybutynin Chloride Er (Oxybutynin Chloride) — 243 prescription fills, including refills.
- Prednisone — 225 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 29 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in Ohio (2024, 320 clinicians with data). Median for this group: 988. Middle half: 503 to 2,208.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 190 in 2020 to 10,800 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
350 W Wilson Bridge Rd Ste 100
Worthington, OH 430852590
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Gahanna, OH. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 2 distinct group names: Central Ohio Urology Group, Llc.; Fairfield Healthcare Professionals Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Wright State University Boonshoft School Of Medicine
2015
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
687 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $299,618 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $226,007 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,426 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$3,189,536 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,190.34 across 52 records.
By nature of payment
- Food and Beverage: $1,190.34 across 52 records.
Reporting-company totals (3 largest of 19)
- Medtronic, Inc.: $170.76 across 4 records.
- ABBVIE INC.: $154.43 across 10 records.
- Sumitomo Pharma America, Inc.: $119.05 across 5 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
11 years (graduated 2015)
CMS Doctors and Clinicians data list 2015 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2015
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Corbett has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Corbett as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Worthington and Ohio
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in Ohio (2024, 320 clinicians with data). Median for this group: 988. Middle half: 503 to 2,208.
Too few clinicians listed under Urology in Worthington have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Urology in Ohio (2024, 320 clinicians with data). Median for this group: $92,108. Middle half: $51,465 to $168,674.
Too few clinicians listed under Urology in Worthington have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Urology in Ohio (2024, 320 clinicians with data). Median for this group: $68,179. Middle half: $36,410 to $123,730.
Too few clinicians listed under Urology in Worthington have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Urology in Ohio (2024, 364 clinicians with data). Median for this group: 951. Middle half: 200 to 1,972.
Too few clinicians listed under Urology in Worthington have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Ohio (2024, 364 clinicians with data). Median for this group: $54,895. Middle half: $8,266 to $180,336.
Too few clinicians listed under Urology in Worthington have Medicare Part D data for 2024 to compare.
9 active clinicians are listed under Urology with a practice address in Worthington, OH (531 in Ohio).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 5584% from 190 in 2020 to 10,800 in 2024.
- 2020: 190
- 2021: 3,321
- 2022: 3,156
- 2023: 8,639
- 2024: 10,800
-
Medicare-allowed amount
Medicare-allowed amount increased 2612% from $11,047 in 2020 to $299,618 in 2024.
- 2020: $11,047
- 2021: $115,906
- 2022: $102,422
- 2023: $144,049
- 2024: $299,618
-
Paid by Medicare
Paid by Medicare increased 2538% from $8,567 in 2020 to $226,007 in 2024.
- 2020: $8,567
- 2021: $97,682
- 2022: $78,375
- 2023: $107,423
- 2024: $226,007
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 1572% from 123 in 2020 to 2,056 in 2024.
- 2020: 123
- 2021: 689
- 2022: 1,108
- 2023: 1,370
- 2024: 2,056
-
30-day fills
30-day fills increased 1712% from 189 in 2020 to 3,426 in 2024.
- 2020: 189
- 2021: 1,112
- 2022: 1,786
- 2023: 2,373
- 2024: 3,426
-
Part D drug cost
Part D drug cost increased 38001% from $8,371 in 2020 to $3,189,536 in 2024.
- 2020: $8,371
- 2021: $58,780
- 2022: $117,060
- 2023: $174,564
- 2024: $3,189,536
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $238.53 in 2021 to $1,190.34 in 2025.
- 2021: $238.53
- 2022: $372.38
- 2023: $411.99
- 2024: $1,941.47
- 2025: $1,190.34
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 52 records totaling $1,190.34.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INTERSTIM | General | $133.33 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
LithoVue | General | $40.76 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
ZUSDURI | General | $37.50 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $33.66 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $33.42 |
| IMMUNITYBIO, INC. |
Food and Beverage
In-kind items and services
|
ANKTIVA | General | $32.00 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $30.36 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $30.22 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
LYNPARZA | General | $28.70 |
| VERTEX PHARMACEUTICALS INCORPORATED |
Food and Beverage
In-kind items and services
|
JOURNAVX | General | $28.23 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $28.14 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $28.09 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
YONSA | General | $26.40 |
| PROGENICS PHARMACEUTICALS, INC. |
Food and Beverage
In-kind items and services
|
PYLARIFY | General | $25.65 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $25.51 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $25.22 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $23.23 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUPRON DEPOT | General | $22.72 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $21.85 |
| IMMUNITYBIO, INC. |
Food and Beverage
In-kind items and services
|
ANKTIVA | General | $21.25 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $20.66 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $20.07 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $20.01 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
LYNPARZA | General | $19.85 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $19.69 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2019–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2020–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J9030
Bcg live intravesical instillation, 1 mg
|
3,650 | 20 | $8.74 | $2.87 |
|
J0897
Injection, denosumab, 1 mg
|
3,060 | 18 | $77.30 | $25.36 |
|
Q9967
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
|
1,100 | 11 | $2.00 | $0.13 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
395 | 264 | $320.25 | $120.57 |
|
99426
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
|
345 | 46 | $178.23 | $58.61 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
286 | 237 | $229.07 | $85.30 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
264 | 30 | $617.61 | $178.47 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
190 | 23 | $180.39 | $59.21 |
|
36415
Insertion of needle into vein for collection of blood sample
|
187 | 112 | $25.63 | $8.65 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
183 | 142 | $25.76 | $10.11 |
|
84153
Psa (prostate specific antigen) measurement, total
|
173 | 110 | $55.00 | $18.02 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
157 | 125 | $47.76 | $15.68 |
|
81003
Automated urinalysis test
|
103 | 91 | $18.69 | $2.20 |
|
81002
Urinalysis, manual test
|
76 | 36 | $10.44 | $3.41 |
|
51720
Instillation of anti-cancer drug into bladder
|
73 | 20 | $250.73 | $82.31 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
69 | 63 | $214.65 | $73.97 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
65 | 65 | $469.93 | $158.26 |
|
84403
Testosterone (hormone) level, total
|
51 | 31 | $77.00 | $25.29 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
45 | 32 | $93.78 | $32.17 |
|
96372
Injection of drug or substance under skin or into muscle
|
41 | 23 | $40.56 | $13.30 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
33 | 33 | $310.69 | $105.31 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
29 | 28 | $160.52 | $52.94 |
|
74420
Imaging of urinary tract following injection of a contrast agent
|
25 | 24 | $86.30 | $23.01 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
19 | 19 | $333.80 | $118.89 |
|
51700
Simple bladder irrigation and/or instillation
|
18 | 16 | $191.12 | $70.42 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 452 | 30,753 | $5,438.59 | 157 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 243 | 13,601 | $4,725.92 | 98 |
| Prednisone | Prednisone | 225 | 7,246 | $696.82 | 37 |
| Abiraterone Acetate | Abiraterone Acetate | 137 | 4,530 | $382,398.49 | 21 |
| Myrbetriq | Mirabegron | 115 | 4,899 | $73,273.45 | 38 |
| Xtandi | Enzalutamide | 108 | 3,240 | $1,318,701.05 | 12 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 108 | 7,380 | $1,768.33 | 37 |
| Finasteride | Finasteride | 90 | 7,740 | $1,102.98 | 29 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 63 | 212 | $168.47 | 59 |
| Testosterone Cypionate | Testosterone Cypionate | 56 | 2,862 | $2,334.89 | 16 |
| Erleada | Apalutamide | 55 | 1,650 | $808,885.14 | — |
| Cefdinir | Cefdinir | 52 | 347 | $712.77 | 49 |
| Orgovyx | Relugolix | 52 | 1,590 | $140,895.42 | — |
| Gemtesa | Vibegron | 38 | 1,754 | $27,958.45 | 13 |
| Solifenacin Succinate | Solifenacin Succinate | 30 | 1,470 | $824.31 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 24 | 1,380 | $1,751.73 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 109 | $70.27 | 20 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 231 | $150.23 | 16 |
| Levofloxacin | Levofloxacin | 18 | 124 | $81.31 | 14 |
| Trospium Chloride Er | Trospium Chloride | 18 | 600 | $1,481.10 | — |
| Nubeqa | Darolutamide | 18 | 540 | $231,859.28 | — |
| Imipramine Hcl | Imipramine Hcl | 16 | 1,050 | $240.67 | — |
| Tadalafil | Tadalafil | 16 | 512 | $865.64 | — |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 15 | 351 | $466.07 | 12 |
| Potassium Citrate Er | Potassium Citrate | 15 | 930 | $1,852.66 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-06-26NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20200610002736
OH
4688986797
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Fairfield Healthcare Professionals Inc
618 Pleasantville Rd, Lancaster, OH 431303346
Phone: 7406894945
Central Ohio Urology Group, Llc.
350 W Wilson Bridge Rd, Worthington, OH 430852585
Phone: 6142682323
Secondary Practice Locations
701 Tech Center Dr
Gahanna, OH 432301987
Phone: 6143962684
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Nurse Practitioner
Nurse Practitioner (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 350 W WILSON BRIDGE RD STE 100, WORTHINGTON, OH 430852590 (Tel: 6147962900)
Registered at 701 TECH CENTER DR STE 250, GAHANNA, OH 432301987 (Tel: 6149444800)
Recorded as JONATHAN CORBETT, MD
Urology (license number reported to NPPES: OH 35.139297)
NPI status registered as active in NPPES database
Registered at 231 ALBERT SABIN WAY, ML 0589, CINCINNATI, OH 452672827 (Tel: 5135580983)
Registered at 231 ALBERT SABIN WAY, ML 0589, CINCINNATI, OH 452672827 (Tel: 5135580983)
Recorded as JONATHAN CORBETT
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Worthington
- Dr. Ronney Abaza, MD
- Dr. Sara Perkins, MD
- Dr. William Bloch, MD
- Dr. Andrew Ng, MD
- Dr. Michael Gambla, MD
- Dr. Matthew Riebel, MD
Mailing Address
701 Tech Center Dr Ste 250
Gahanna, OH 432301987
Phone: 6149444800